Ben Rome
@benro.me
580 followers
370 following
49 posts
Primary care doc, health policy researcher @portalresearch.org. Trying to make prescription drugs more affordable. 💊🩺📊
Posts
Media
Videos
Starter Packs
Reposted by Ben Rome
Aaron Kesselheim
@akesselheim.bsky.social
· Jun 28
Congress Should Remove The Rare Disease Carve-Out From Medicare Drug Price Negotiation, Not Expand It | Health Affairs Forefront
Expansion of the Medicare drug price negotiation rare disease drug carve-out would unnecessarily limit the number of drugs eligible for negotiation, allow for continued high drug prices for products that earn billions of dollars in Medicare, and introduce a new set of misaligned incentives.
www.healthaffairs.org
Reposted by Ben Rome
Reposted by Ben Rome
Reposted by Ben Rome
Reposted by Ben Rome
Reposted by Ben Rome
Aaron Kesselheim
@akesselheim.bsky.social
· Jan 31
How to protect HHS, FDA, NIH, and other health agencies from political interference
When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts and inflict lasting damage on institutional credibility.
www.statnews.com
Reposted by Ben Rome
Aaron Kesselheim
@akesselheim.bsky.social
· Jan 31
How to protect HHS, FDA, NIH, and other health agencies from political interference
When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts and inflict lasting damage on institutional credibility.
www.statnews.com
Reposted by Ben Rome
Aaron Kesselheim
@akesselheim.bsky.social
· Dec 13
Will The New Administration’s FDA Be A Threat Or An Opportunity For The Public's Health? | Health Affairs Forefront
As various reform ideas are proposed, the organized medical and scientific community will need to work with the new leadership at the FDA to promote positive change–and oppose initiatives that undermi...
www.healthaffairs.org
Reposted by Ben Rome
Aaron Kesselheim
@akesselheim.bsky.social
· Dec 13
Will The New Administration’s FDA Be A Threat Or An Opportunity For The Public's Health? | Health Affairs Forefront
As various reform ideas are proposed, the organized medical and scientific community will need to work with the new leadership at the FDA to promote positive change–and oppose initiatives that undermi...
www.healthaffairs.org